India

India, officially known as the Republic of India, is located in Southeast Asia. By area it’s the seventh largest country in the world, and is the second most populous, with 1.2 billion residents. It is the world’s most populous democracy.

In 2017, the economy was the seventh largest in the world by nominal GDP, and had the world’s third largest purchasing power parity. India became one of the world’s fastest growing economies following the market-based economic reforms of 1991. Since this period the country has been considered a newly industrialized nation. It is considered a regional power and nuclear weapons state, and the country has the world’s second largest standing army. It ranks fifth in the world in military expenditures.

The country is based on a parliamentary system with 29 states and 7 union territories. As the world’s most populous democracy, the Indian government is a multi-party system, with 7-recognized national parties. Today, Congress and the  Bharatiya Janata Party (BJP) share parliamentary control. The Constitution of India is the serves as the law of the land; the government abides by Constitutional checks and balances, and the Constitution claims India as a sovereign, socialist, secular, democratic republic. The government is broken down into the legislature, judicial, and executive branches.

According to the  International Monetary Fund (IMF), in 2017 India’s economy was valued at US$2.454 trillion. Emphasis on trade, direct investments, and foreign markets, are among the leading drivers of the Indian economy. Major agricultural production of rice, wheat, cotton, and tea, are also prominently exported from the country. Telecommunications, chemicals, textiles, machinery and software, mining, steel transport, petroleum, food processing, biotechnology, and engineering goods, are among the many areas which the country relies upon, for its economic gains.

The National Law Review covers news, stories, and the latest developments in India, and between Indian and US relations. Trade, pharmaceuticals, biotechnology, labor and employment issues, ADCV (anti-dumping and countervailing laws), and news in the area of cybersecurity, technology and data privacy, are among the many stories covered by the National Law Review. Visitors will always find the latest developments, stories, and relevant content about India and international developments with the United States, and other countries around the world.

 

Custom text Title Organization Sort descending
Sep
27
2013
Canada's First Foreign Bribery Conviction Shows Trend in Increased Enforcement Sheppard, Mullin, Richter & Hampton LLP
Jun
18
2013
Section 3(d) of the Indian Patents Act – Part II Michael Best & Friedrich LLP
Jan
6
2014
BRIC-a-BRAC: News Items from Brazil, Russia, India and China January 6, 2014 Michael Best & Friedrich LLP
May
16
2016
Much Awaited Indian National IPR Policy Has Arrived! Michael Best & Friedrich LLP
Jun
21
2013
Proposed Increase in Official Fees in Connection with Patent Filings in India Michael Best & Friedrich LLP
Jan
9
2014
Has Inequitable Conduct Come to India? Re: Patent Applications Michael Best & Friedrich LLP
Apr
23
2014
The Copaxone Story in the U.S. and India: To Stay or Not to Stay is the Question Michael Best & Friedrich LLP
Jan
24
2014
BRIC-a-BRAC January 24, 2014: News Items from BRIC Countries Michael Best & Friedrich LLP
Aug
9
2013
Recent Decisions involving Section 3(d) of the Indian Patents Act Michael Best & Friedrich LLP
Jan
31
2014
BRIC-a-BRAC: News Items from BRIC Companies January 31, 2014 Michael Best & Friedrich LLP
May
21
2014
An Overview of Biosimilars and the Biosimilar Pathway in India Michael Best & Friedrich LLP
Feb
5
2014
BRIC-a-BRAC February 5, 2014: News Items from BRIC Countries Michael Best & Friedrich LLP
Dec
8
2014
The Breadth of India’s “Bolar Exemption” Michael Best & Friedrich LLP
Feb
17
2014
Patent Trolls: A Global Perspective Re: Patent Infringement Michael Best & Friedrich LLP
Sep
18
2015
Indian Patent Office Rejects Pfizer’s Patent for Tofacitinib – Again! Michael Best & Friedrich LLP
Aug
29
2013
Section 8 of the Indian Patents Act and a Comparison with the Disclosure Requirements in Canada, Israel and the U.S. Michael Best & Friedrich LLP
Mar
6
2014
The Copaxone Story in the U.S. and India Michael Best & Friedrich LLP
Jul
10
2014
The Thorny Problem of Patentable Eligible Subject Matter: Part 3 of a 10-Part Series: India Michael Best & Friedrich LLP
Mar
14
2014
BRIC-a-BRAC: March 14, 2014 Michael Best & Friedrich LLP
Apr
2
2015
Pre- and Post-Grant Oppositions in India – Part 3 of an 8 Part Series Michael Best & Friedrich LLP
Jan
8
2016
January 8, 2016 -- Biologics and Biosimilars Bits and Bytes Michael Best & Friedrich LLP
May
17
2013
Organizational Structure & the Working of the Indian Patent Office Michael Best & Friedrich LLP
Nov
13
2013
Divisional Practice in the BRICs (Brazil, Russia, India and China) and other Countries – Part 1 of a 9-Part Series Michael Best & Friedrich LLP
Mar
19
2014
Divisional Practice in the BRICs and other Countries – Part 8 of a 9-Part Series: Europe Michael Best & Friedrich LLP
Jan
29
2016
Part 3 – Foreign Filing Restrictions and Licenses in India Michael Best & Friedrich LLP
May
18
2013
Understanding Compulsory Licenses in India – Part 1 of a 2-Part Series Michael Best & Friedrich LLP
Apr
2
2014
Divisional Practice in the BRICs and other Countries – Part 9 of a 9-Part Series: A Comprehensive Summary Michael Best & Friedrich LLP
Jan
6
2017
Delhi High Court Strikes Down Section 24(5) of the Plant Varieties Act as Unconstitutional Michael Best & Friedrich LLP
May
20
2013
Understanding Compulsory Licenses in India – Part 2 of a 2-Part Series Michael Best & Friedrich LLP
Dec
10
2013
Divisional Practice in the BRICs and other Countries – Part 4 of a 9-Part Series Michael Best & Friedrich LLP
Apr
4
2014
The Copaxone Story in the U.S. and India: An Update Michael Best & Friedrich LLP
Apr
22
2016
India Patent Office Decision Denying Cipla’s Patent Application for an Anti-Retroviral Combination Michael Best & Friedrich LLP
Jun
8
2013
Section 3(d) of the Indian Patents Act – Part I Michael Best & Friedrich LLP
Apr
10
2014
The Copaxone Story in the U.S. and India: A Further Update Michael Best & Friedrich LLP
May
16
2016
Indian Patent Office's Patent to Gilead’s Sovaldi Challenged at Delhi High Court Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins